HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ProMune (CpG 7909)

an anticancer adjuvant and immunostimulant
Also Known As:
CpG 7909; CpG 7907; CpG 8916; CpG 8954; CpG-7907; CpG-7909; CpG-8916; CpG-8954; CpG7907; CpG7909; CpG8916; CpG8954; PF 3512676; PF-3512676; PF3512676
Networked: 53 relevant articles (6 outcomes, 30 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Krieg, Arthur M: 8 articles (05/2009 - 03/2005)
2. Ellis, Ruth D: 6 articles (12/2014 - 01/2008)
3. Miura, Kazutoyo: 6 articles (12/2014 - 01/2008)
4. Long, Carole A: 5 articles (12/2014 - 07/2007)
5. Link, Brian K: 5 articles (07/2013 - 09/2006)
6. Fay, Michael P: 5 articles (01/2012 - 01/2008)
7. Mullen, Gregory E D: 5 articles (01/2010 - 07/2007)
8. Zhu, Daming: 4 articles (12/2014 - 01/2008)
9. Weiner, George J: 4 articles (07/2013 - 09/2006)
10. Rausch, Kelly: 4 articles (01/2012 - 07/2007)

Related Diseases

1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
2. Renal Cell Carcinoma (Grawitz Tumor)
3. Infection
4. Neoplasms (Cancer)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. Toll-Like Receptors (Toll-Like Receptor)
2. Toll-Like Receptor 9
3. Paclitaxel (Taxol)
4. Carboplatin (JM8)
5. Platinum
6. Cisplatin (Platino)
7. taxane
8. gemcitabine
9. ProMune (CpG 7909)
10. Antigens

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Immunotherapy
3. Radioimmunotherapy
4. Highly Active Antiretroviral Therapy (HAART)
5. Stents